PLX Protalix BioTherapeutics, Inc. Common Stock · XASE
2.96 +15.0% as of Nov 10, 13:55 ET
fans
What's happening Live detector signal Generated 00:51 ET
Share structure
Free float
75.0M
2026-05-15
Shares out
80.6M
latest detail
Market cap
$230.4M
at ref price
Short interest
4.6%
2026-10-30
Float rotation
0.03×
latest snapshot
20d dollar vol
$2.1M
baseline
Supply intelligence
Gap quality
mixed supply · 50
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
large float supply
detector reason
Supply factor
microcap supply profile
detector reason

This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.

Filings and news
2026-11-10 13:55 ETSignalProtalix BioTherapeutics, Inc. Common Stock is up 15.0%, at 2.96, on $5.6M traded, 2.7× 20-day volume. Score 70. Primary driver: $5.6M traded. Supply intelligence: mixed supply · 50.
2026-11-1010-QQuarterly report SEC
2026-11-108-KItem 2.02 — Results of operations and financial condition; Item 9.01 — Financial statements and exhibits SEC
2026-08-1210-QQuarterly report SEC
2026-08-128-KItem 2.02 — Results of operations and financial condition; Item 9.01 — Financial statements and exhibits SEC
2026-06-258-KItem 9.01 — Financial statements and exhibits SEC
2026-05-218-KItem 7.01 — Regulation FD disclosure; Item 9.01 — Financial statements and exhibits SEC
Latest detector signalscore 70
score 70